Among overweight individuals—even those not meeting obesity criteria—multidomain lifestyle interventions targeting structured dietary control, increased physical activity, and circadian rhythm optimization are warranted to enhance insulin sensitivity and mitigate disease progression. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.